Inventor · disambiguated record
Simon Nicolas Haydar
Also filed as: CHEN WENTING · HAYDAR SIMON · HAYDAR SIMON N · HAYDAR SIMON NICOLAS
20 granted patents·18 pending applications·968 citations·filing 2000–2023
95Inventor score
Files withASSEMBLY BIOSCIENCES INC13BRISTOL MYERS SQUIBB PHARMA CO6WYETH CORP5ALBANY MOLECULAR RES INC1AMR TECHNOLOGY INC1
Top patents by PatentIndex Score
38 records- 0198US7183282B2Substituted heterocycle fused γ-carbolinesBRISTOL MYERS SQUIBB PHARMA CO·Filed 2006·Granted Feb 27, 2007·145 cites·4 claims
- 0298US6552017B1Substituted heterocycle fused gamma-carbolinesBRISTOL MYERS SQUIBB PHARMA CO·Filed 2000·Granted Apr 22, 2003·208 cites·21 claims
- 0397USRE39680ESubstituted heterocycle fused gamma-carbolinesBRISTOL MYERS SQUIBB PHARMA CO·Filed 2006·Granted Jun 5, 2007·142 cites·21 claims
- 0497USRE39679ESubstituted heterocycle fused gamma-carbolinesBRISTOL MYERS SQUIBB PHARMA CO·Filed 2006·Granted Jun 5, 2007·129 cites·33 claims
- 0597US7071186B2Substituted heterocycle fused gamma-carbolinesBRISTOL MYERS SQUIBB PHARMA CO·Filed 2004·Granted Jul 4, 2006·121 cites·15 claims
- 0697US6713471B1Substituted heterocycle fused gamma-carbolinesBRISTOL MYERS SQUIBB PHARMA CO·Filed 2000·Granted Mar 30, 2004·172 cites·33 claims
- 0795US9012642B2Pyrrolopyridinone compounds and methods for treating HIVVIIV HEALTHCARE UK LTD·Filed 2012·Granted Apr 21, 2015·36 cites·6 claims
- 0893US10377748B2Hepatitis B core protein modulatorsASSEMBLY BIOSCIENCES INC·Filed 2016·Granted Aug 13, 2019·6 cites·3 claims
- 0984US2024025890A1Hepatitis b core protein modulatorsASSEMBLY BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 1078US11560370B15-membered heteroaryl carboxamide compounds for treatment of HBVASSEMBLY BIOSCIENCES INC·Filed 2019·Granted Jan 24, 2023·1 cites·30 claims
- 1176US11078170B2Cyclic sulfamide compounds and methods of using sameASSEMBLY BIOSCIENCES INC·Filed 2018·Granted Aug 3, 2021·1 cites·35 claims
- 1275US11814376B2Hepatitis b core protein modulatorsASSEMBLY BIOSCIENCES INC·Filed 2021·Granted Nov 14, 2023·0 cites·6 claims
- 1372US12030869B25-membered heteroaryl carboxamide compounds for treatment of HBVASSEMBLY BIOSCIENCES INC·Filed 2022·Granted Jul 9, 2024·0 cites·5 claims
- 1471US7939520B2Aminoazacyclyl-3-sulfonylindazoles as 5-hydroxytryptamine-6 ligandsWYETH LLC·Filed 2008·Granted May 10, 2011·1 cites·29 claims
- 1570US10968211B2Hepatitis B core protein modulatorsASSEMBLY BIOSCIENCES INC·Filed 2019·Granted Apr 6, 2021·0 cites·12 claims
- 1666US7538084B2CyclosporinsAMR TECHNOLOGY INC·Filed 2004·Granted May 26, 2009·4 cites·8 claims
- 1765US8063053B21-(arylsulfonyl)-4-(piperazin-1-yl)-1H-benzimidazoles as 5-hydroxytryptamine-6 ligandsHAYDAR SIMON NICOLAS·Filed 2009·Granted Nov 22, 2011·1 cites·18 claims
- 1862US2022023311A1Hepatitis b core protein modulatorsASSEMBLY BIOSCIENCES INC·Filed 2021·Application pending·0 cites
- 1961US2023012463A1Cyclic sulfamide compounds and methods of using sameASSEMBLY BIOSCIENCES INC·Filed 2021·Application pending·0 cites
- 2060US2025282803A1Didehydro-3'-deoxy-4'-ethynylthymidines and related compounds and their use in treating medical conditionsROME THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2156US10987360B2Hepatitis B core protein modulatorsASSEMBLY BIOSCIENCES INC·Filed 2017·Granted Apr 27, 2021·0 cites·16 claims
- 2256US8163729B2Modulators of α7 nicotinic acetylcholine receptors and therapeutic uses thereofGHIRON CHIARA·Filed 2008·Granted Apr 24, 2012·1 cites·19 claims
- 2355US2004034015A1Substituted heterocycle fused gamma-carbolinesFiled 2003·Application pending·0 cites
- 2454US2023295096A1Pyrazole carboxamide compounds for treatment of hbvASSEMBLY BIOSCIENCES INC·Filed 2021·Application pending·0 cites
- 2550US2008194637A1Small organic molecule regulators of cell proliferationCURIS INC·Filed 2007·Application pending·0 cites
- 2646US2009264384A1Indole, benzimidazole, and benzolactam boronic acid compounds, analogs thereof and methods of use thereofNUADA INC·Filed 2008·Application pending·0 cites
- 2746US2022081433A1Cyclic sulfamide compounds for treatment of hbvASSEMBLY BIOSCIENCES INC·Filed 2019·Application pending·0 cites
- 2846US2009181952A1Compounds useful as alpha7 nicotinic acetylcholine receptor agonistsWYETH CORP·Filed 2009·Application pending·0 cites
- 2946US2010016598A1Alpha7 nicotinic acetylcholine receptor inhibitorsWYETH CORP·Filed 2009·Application pending·0 cites
- 3046US2023075856A1Cyclic sulfamide compounds for treatment of hbvASSEMBLY BIOSCIENCES INC·Filed 2019·Application pending·0 cites
- 3146US2010016360A1Alpha7 nicotinic acetylcholine receptor inhibitorsWYETH CORP·Filed 2009·Application pending·0 cites
- 3243US2010016343A1Alpha7 nicotinic acetylcholine receptor inhibitorsWYETH CORP·Filed 2009·Application pending·0 cites
- 3343US2010130474A1Alpha7 nicotinic acetylcholine receptor inhibitorsWYETH CORP·Filed 2009·Application pending·0 cites
- 3442US6747039B2Aza-benzothiopyranoindazoles with antitumor activityALBANY MOLECULAR RES INC·Filed 2002·Granted Jun 8, 2004·0 cites·52 claims
- 3541US2003212061A1Aza-thioxanthenones with antitumor activityFiled 2002·Application pending·0 cites
- 3639US9029391B2Isoquinoline compounds and methods for treating HIVDE LA ROSA MARTHA ALICIA·Filed 2012·Granted May 12, 2015·0 cites·5 claims
- 3738US2009005344A1Compounds and Methods of Use ThereofNKUADA LLC·Filed 2005·Application pending·0 cites
- 3835US2008319044A1Compounds and Methods of Use ThereofNUADA LLC·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Simon Nicolas Haydar files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →